Section Arrow
NVAX.NASDAQ
- Novavax
Quotes are at least 15-min delayed:2025/03/28 05:26 EDT
Last
 7.26
-0.13 (-1.76%)
Day High 
7.42 
Prev. Close
7.39 
1-M High
8.63 
Volume 
2.60M 
Bid
7.3
Ask
7.38
Day Low
7.24 
Open
7.36 
1-M Low
7.02 
Market Cap 
1.19B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.84 
20-SMA 7.88 
50-SMA 8.2 
52-W High 23.8599 
52-W Low 3.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.23/-1.07
Enterprise Value
1.41B
Balance Sheet
Book Value Per Share
-3.88
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
682.16M
Operating Revenue Per Share
6.05
Created with Highstock 5.0.121-min Chart12:0015:007.27.257.37.357.47.45etnet.com.hk@copyright
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 05:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly ownedSwedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Thecompany manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.